Use of heparin-binding antagonists in the inhibition of bradykinin release

Details for Australian Patent Application No. 2005203787 (hide)

Owner Novo Nordisk A/S

Inventors Bjorn, Soren; Lindbom, Lennart; Flodgaard, Hans Jakob

Agent Shelston IP

Pub. Number AU-A-2005203787

Parent 781734

Filing date 23 August 2005

Wipo publication date 15 September 2005

International Classifications

A61K 038/55 Medicinal preparations containing peptides - Protease inhibitors

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 014/81 Peptides having more than 20 amino acids - Protease inhibitors

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 September 2005 Complete Application Filed

15 September 2005 Application Open to Public Inspection

  Published as AU-A-2005203787

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005203788-Aqueous, non-alcoholic liquid powder formulations

2005203786-System and method for updating message trust status